Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5

Area of Science:

• Cell biology
• Molecular oncology
• Pharmacology

Background:

• Cancer chemotherapy efficacy is limited by variable drug sensitivity in cancer and normal cells.
• Understanding the molecular mechanisms underlying drug response is crucial for improving cancer treatment outcomes.

Purpose of the Study:

• To investigate the phenotypic and molecular determinants of sensitivity to antimitotic drugs across diverse cell lines.
• To identify factors influencing apoptosis induction following treatment with paclitaxel, nocodazole, and a kinesin-5 inhibitor.

Main Methods:

• High-content screening using automated microscopy to assess mitosis and apoptosis markers.
• Phenotypic analysis of drug response across 11 cell lines.
• Molecular analysis of apoptotic signaling pathways and protein expression (XIAP, p38, c-Jun NH2 kinase).

Main Results:

• Mitotic arrest response was consistent across cell lines, while apoptosis induction varied significantly.
• No direct correlation was observed between the level of mitotic arrest and subsequent apoptosis.
• Apoptosis sensitivity correlated with the loss of XIAP during drug response and activation of p38 and c-Jun NH2 kinase pathways.
• Paclitaxel induced higher apoptosis in some cell lines compared to other drugs at similar mitotic arrest levels.

Conclusions:

• Cellular sensitivity to antimitotic drugs is primarily determined by differences in apoptotic signaling pathways rather than variations in mitotic spindle or spindle assembly checkpoint proteins.
• Antimitotic drugs with distinct mechanisms of action elicit largely similar, though not identical, cellular responses.
• These findings provide insights into optimizing cancer chemotherapy by targeting apoptotic pathways.